
By Peter Nurse
Investing.com -- Stocks in focus in premarket trade on Thursday, August 4th. Please refresh for updates.
ConocoPhillips (NYSE:COP) stock rose 3.5% after the oil giant raised its planned capital returns to $15 billion for 2022 after posting a more than doubling of its second-quarter profit.
Eli Lilly (NYSE:LLY) stock fell 2.8% after the drugmaker cut its full-year profit forecast for the second time after reporting a hefty slump in quarterly profit on Thursday, hurt by lower prices of insulin and competition for its cancer drug, Alimta.
Restaurant Brands (NYSE:QSR) stock rose 4.2% after the parent of a number of fast food chains topped quarterly earnings and sales forecasts, helped by international sales growth at Burger King.
Alibaba (NYSE:BABA) ADRs rose 4.1% after the Chinese e-commerce giant beat market expectations for revenue in the quarter ending late June, even though growth was flat for the first time ever due to the impact of COVID-19 lockdowns.
Cigna (NYSE:CI) stock rose 3.6% after the health insurer raised its annual profit forecast after its quarterly earnings beat estimates as a slow recovery in non-urgent medical procedures helped rein in medical expenses.
Thomson Reuters (NYSE:TRI) stock rose 0.8% after the media giant reported higher second-quarter operating profit and raised its full-year revenue forecast.
Under Armour (NYSE:UA) stock fell 1.3% after Baird downgraded its investment stance on the sports equipment company to ‘neutral’ from ‘outperform’, losing confidence in its ability to weather the current economic backdrop.
Aptiv (NYSE:APTV) stock fell 10% after the auto parts supplier lowered its full-year revenue and profit forecast, with a semiconductor shortage and rising costs weighing on global vehicle production.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.